Home » Topics » BioWorld Science

BioWorld Science
RSS

Roche starts phase I study of RO-7296682 in advanced solid tumors

Jan. 2, 2020

Genmab studies GEN-1042 safety for malignant solid tumors in phase I/IIa trial

Jan. 2, 2020

Regeneron begins open-label extension study with REGN-3918 in PNH

Jan. 2, 2020

Roche identifies new TLR7/8/9 antagonists

Jan. 2, 2020

Pfizer divulges new GLP-1R agonists

Jan. 2, 2020

Ryvu Therapeutics identifies hSTING receptor agonists

Jan. 2, 2020

New compounds for hepatitis B virus presented by VenatoRx Pharmaceuticals

Jan. 2, 2020

Amgen patents KRAS mutant inhibitors

Jan. 2, 2020

China NMPA approves Cecolin HPV16/18 vaccine

Jan. 2, 2020

Herantis advances xCDNF program into lead optimization

Jan. 2, 2020

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...